Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake - Test2 - elhamkhani - TriplyDB

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake

http://www.wikidata.org/entity/Q24646913

about

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly Role of HIV in amyloid metabolism Brain imaging in Alzheimer disease Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model.Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers PET amyloid-beta imaging in preclinical Alzheimer's disease Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.Promoting successful cognitive aging: a comprehensive review.Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease Cognitive resilience in clinical and preclinical Alzheimer's disease: the Association of Amyloid and Tau Burden on cognitive performance.How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study.Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve.Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease.In vivo human amyloid imaging.Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease Review of topiramate for the treatment of epilepsy in elderly patients.Mapping brain beta-amyloid.Comparison of 18F-FDG and PiB PET in cognitive impairment.Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept.The synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and research Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults.Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease Cognition, reserve, and amyloid deposition in normal aging.Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition Amyloid imaging and memory change for prediction of cognitive impairment.Quantitative analysis of PiB-PET with FreeSurfer ROIs Face-name associative memory performance is related to amyloid burden in normal elderly.Supporting performance in the face of age-related neural changes: testing mechanistic roles of cognitive reserve.Cerebrospinal fluid biomarkers, education, brain volume, and future cognition For debate: substituting placebo controls in long-term Alzheimer's prevention trials.PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease Globalization of Alzheimer's disease clinical trials An overview of nonpathological geroneuropsychology: implications for nursing practice and research.APOE modifies the association between Aβ load and cognition in cognitively normal older adults.

P2860

Q24594531-FA10A5C6-1575-4643-BEAF-444F57B2697B Q24634788-60B820D2-4A31-4394-A4B9-E062B14A0AB3 Q26824179-3FE372C5-FA19-4661-A739-F78D63BCE3C1 Q26996299-7E0B705B-91B6-4F76-BB7B-D23C0E8091D5 Q28247764-8D66D18D-65C3-4830-A0FF-13112C272905 Q29620245-DA0E3CF5-B676-408B-B0CE-30F90A105055 Q30040695-C83CDFF8-D15B-41FE-96D0-198E8612D317 Q30422060-022CDB9E-586D-4B16-A24B-2E1DD102FE16 Q33544151-9637D948-03AE-4A13-AD30-1847EA7A49CB Q33560183-FD55C0F0-C35B-4A2B-921E-5FE18E1CAF3B Q33563786-708D8407-B905-40F9-8AAE-5964A02F6D1D Q33606033-EE051C93-DAA0-4863-8FA4-54669C932851 Q33656333-993C56AD-8385-42D3-871D-D7DD1B278531 Q33769079-6C421028-F39F-4118-BD28-FD8B476D4475 Q33790277-8837158F-DEF2-4BDA-959E-DEE0E2536F02 Q33793583-70005693-5D8A-4A9B-A767-BCD9D1B2CCC1 Q33819386-EFD1B0B5-06F9-4955-9B43-351B5187C592 Q33899600-2BED04AB-02E0-4BC4-B78F-923D58DAC159 Q33917282-530C6CB4-B52F-4E03-A49F-362A7411BE35 Q34002802-DD9C5E47-E4BD-45AF-876B-3B22FC01D2F4 Q34004313-D170C124-F8B1-4799-B8C5-345B05F8CBD3 Q34143299-40629379-115D-4E86-B9F2-A9FBE682CC14 Q34311853-294DDC9D-67D5-480F-BFAB-53FAC80C4764 Q34630235-6ACC1ACD-3CE7-4402-BCF4-AB4889A81525 Q34646071-3AAA885C-F5A9-403A-9FBB-D829F700870F Q34783920-ABFE5F42-77FF-4A78-9414-4369F84CF397 Q34833657-BE168464-91BD-4279-85CE-29E14164C33F Q34865982-7ECB4753-264C-4119-B67A-9DAACEA2C077 Q34922621-0CF8B9DD-B52F-4233-A15D-A31E8AB56AEE Q34992153-6DBBE367-B9F4-49E8-BEF2-2622FCD8C2AC Q35029095-CCA9EA1A-D003-4DB5-9181-34C8C8E60103 Q35040068-44D3969B-0E62-4728-97EF-006F7B50B342 Q35109364-FB0D35A1-B990-437F-B42C-F4B7415BE77E Q35205017-F19C5B16-1F34-45AB-89BE-1E24431B2597 Q35469471-8E13F861-6299-4E01-B9C7-A75DCFA113FD Q35579221-8E6F8A4D-B464-4D1C-B1A8-3B83BDF74783 Q35579225-F4FF4EAA-0ECC-4BC8-AF01-04B2B47C2A8C Q35579247-6A43B0DE-3780-4D79-AFA7-04BA1A9E58E3 Q35655113-A4F350CB-CF4C-4D08-BFE6-DF3EBE78F9F3 Q35758673-59492E8F-A796-4EC8-9120-9CDA6A113E59

P2860

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake

http://www.wikidata.org/entity/Q24646913

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Alzheimer disease and cognitiv ...... d Pittsburgh Compound B uptake

@ast

Alzheimer disease and cognitiv ...... d Pittsburgh Compound B uptake

@en

Alzheimer disease and cognitiv ...... d Pittsburgh Compound B uptake

@nl

type

label

Alzheimer disease and cognitiv ...... d Pittsburgh Compound B uptake

@ast

Alzheimer disease and cognitiv ...... d Pittsburgh Compound B uptake

@en

Alzheimer disease and cognitiv ...... d Pittsburgh Compound B uptake

@nl

prefLabel

Alzheimer disease and cognitiv ...... d Pittsburgh Compound B uptake

@ast

Alzheimer disease and cognitiv ...... d Pittsburgh Compound B uptake

@en

Alzheimer disease and cognitiv ...... d Pittsburgh Compound B uptake

@nl

P1433

Q24646913-0585F987-D66B-49CC-83D8-DBD14D233467

P1476

Q24646913-D8AD5ECF-1A89-43D1-9D32-EA45D1376017

P2093

Q24646913-233CBB9B-2B23-4A51-AC48-9FD30B1375F1

Q24646913-A7594812-F00C-4BE1-B51C-83E957357B05

Q24646913-CB5A96D9-BB24-4F2B-9B0D-71BB4B5241E6

Q24646913-E79AB9A2-A401-4B2F-811D-F9844CFAEE73

P2860

Q24646913-24FFD1AB-6C2F-4093-8776-295D754D7870

Q24646913-2CAE5C82-BF45-4A73-9E3A-56B9C4417C21

Q24646913-2D69C269-F2E6-4E3E-A1A1-53B3E445A649

Q24646913-3CC62F6E-981C-4B10-B488-5177C09B28E1

Q24646913-3FAA6B16-94BA-4CD1-8885-3720C2FF168F

Q24646913-491C5F31-2D7F-4221-8EEB-C70D094804BA

Q24646913-4C1124DE-42F5-40EE-8B74-CD9B817E8820

Q24646913-4C9DC8A4-1F86-4426-9041-B86ACAD35F53

Q24646913-67E5005B-4FA2-4551-BFAD-19A0DFA70C39

Q24646913-9302EC12-F7AE-4219-9F84-C6B633CE7D5B

P304

Q24646913-CD408665-0CFF-4816-9915-7461586E5C78

P31

Q24646913-8FCFE031-5873-4399-9CA9-A225DB86C5E5

P356

Q24646913-DD6075C4-C8E1-4A61-8D87-1B7E2A20BFBD

P407

Q24646913-4036BA03-C35E-4DD2-99EA-AA71B460130E

P433

Q24646913-98495BEA-6430-4F40-B5C9-ACA127BEA8AB

P478

Q24646913-E5E399E8-33A5-4340-896E-B002CACE9210

P50

Q24646913-063AC2D9-0CEA-4925-A5F7-E9373BB17D76

Q24646913-87580C25-A503-4793-858B-B067190E1E85

P577

Q24646913-5CDB44CF-2F66-4A4F-820B-F8A07AD8C496

P5875

Q24646913-C9D95FD6-38B7-423A-9C39-F94C5D005886

P698

Q24646913-08C1B43A-53C7-4135-9A05-55D7E4AAB7D7

P921

Q24646913-39C5AFED-99CC-4914-8B7E-85022BA4C99B

P932

Q24646913-7CF53629-C02F-4B6F-9AA5-BDDC4694238D

P356

ARCHNEUR.65.11.1467

P1433

P1476

Alzheimer disease and cognitiv ...... d Pittsburgh Compound B uptake

@en

P2093

Catherine M Roe

http://www.w3.org/2001/XMLSchema#string

Chengjie Xiong

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Grant

http://www.w3.org/2001/XMLSchema#string

Gina D'Angelo

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive Reserve and Alzheimer Disease

“Mini-mental state”

Education modifies the relation of AD pathology to level of cognitive function in older persons

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

The Clinical Dementia Rating (CDR): current version and scoring rules

A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume.

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression.

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease.

P304

1467-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUR.65.11.1467

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23465653

http://www.w3.org/2001/XMLSchema#string

P698

19001165

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2752218

http://www.w3.org/2001/XMLSchema#string